Gainers
- AVX Corporation (NYSE:AVX) shares climbed 36.4% to close at $20.51 on Wednesday after Kyocera announced a proposal to acquire all shares of the company it does not own for $19.50 per share.
- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA) gained 35.7% to close at $6.27 after climbing 28.69% on Tuesday.
- Onconova Therapeutics Inc (NASDAQ:ONTX) shares gained 33.9% to close at $0.1593.
- GTT Communications, Inc. (NYSE:GTT) rose 25.7% to close at $8.57.
- Ovid Therapeutics Inc. (NASDAQ:OVID) gained 19.2% to close at $3.72.
- Internet Gold - Golden Lines Ltd. (NASDAQ:IGLD) climbed 20.1% to close at $14.60.
- 360 Finance, Inc. (NASDAQ:QFIN) rose 16.7% to close at $9.15 following Q3 results.
- Abeona Therapeutics Inc. (NASDAQ:ABEO) rose 16.2% to close at $3.40.
- Ocugen Inc (NASDAQ:OCGN) gained 15.9% to close at $0.3580 after Chardan Capital initiated coverage on the company's stock with a Buy rating and a $2 price target. The company also reported insider buying of 200K shares.
- Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) rose 15.8% to close at $3.74.
- Myovant Sciences Ltd. (NYSE:MYOV) gained 14.8% to close at $17.24.
- ObsEva SA (NASDAQ:OBSV) rose 13.9% to close at $4.19.
- Spring Bank Pharmaceuticals, Inc. (NASDAQ:SBPH) climbed 13.9% to close at $3.70.
- Clovis Oncology, Inc. (NASDAQ:CLVS) surged 13.6% to close at $12.41.
- InflaRx N.V. (NASDAQ:IFRX) gained 12.7% to close at $3.47.
- Alimera Sciences, Inc. (NASDAQ:ALIM) climbed 12.7% to close at $5.61.
- Precision BioSciences, Inc. (NASDAQ:DTIL) rose 12.5% to close at $18.18
- Diplomat Pharmacy, Inc. (NYSE:DPLO) climbed 12.2% to close at $4.90 on continued upward momentum. The stock dropped roughly 58% following mixed Q3 earnings. It is still trading within that gap.
- Eyenovia, Inc. (NASDAQ:EYEN) rose 12% to close at $4.10.
- Ocular Therapeutix, Inc. (NASDAQ:OCUL) surged 12% to close at $3.55.
- Albireo Pharma, Inc. (NASDAQ:ALBO) gained 11.7% to close at $22.04.
- Banco BBVA Argentina S.A. (NYSE:BBAR) rose 11.7% to close at $4.00.
- Akebia Therapeutics, Inc. (NASDAQ:AKBA) shares surged 11.7% to close at $5.55
- Ossen Innovation Co., Ltd. (NASDAQ:OSN) gained 11.5% to close at $3.30.
- Protagonist Therapeutics, Inc. (NASDAQ:PTGX) climbed 11.5% to close at $8.70.
- Box Inc (NYSE:BOX) rose 11.5% to close at $18.62 after the company reported better-than-expected Q3 sales results.
- Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) shares rose 11.4% to close at $1.17 after the company announced it received the official minutes from the Breakthrough Therapy Type B Clinical Guidance meeting with the FDA for Tonmya. The minutes are consistent with guidance received at the meeting.
- Manchester United plc (NYSE:MANU) gained 11.2% to close at $18.62.
- Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX) surged 11.2% to close at $5.07.
- Harpoon Therapeutics, Inc. (NASDAQ:HARP) gained 11.1% to close at $18.75.
- Axcella Health Inc. (NASDAQ:AXLA) rose 10.9% to close at $3.97.
- Aptinyx Inc. (NASDAQ:APTX) gained 10.8% to close at $3.89.
- Sculptor Capital Management, Inc. (NYSE:SCU) surged 10.4% to close at $19.50.
- FinVolution Group (NYSE:PPDF) rose 9.8% to close at $2.70 after gaining 5.13% on Tuesday.
- ImmunoGen, Inc. (NASDAQ:IMGN) gained 8.9% to close at $3.69.
- McDermott International Inc (NYSE:MDR) climbed 8.3% to close at $0.8159.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Check out these big penny stock gainers and losers
Losers
- Evolent Health, Inc. (NYSE:EVH) shares tumbled 27.3% to close at $7.76 on Wednesday after Passport Health, which is owned by the company, was left out of large Medicaid contracts in Kentucky.
- Baudax Bio, Inc. (NASDAQ:BXRX) dropped 18.4% to close at $5.60.
- Central Garden & Pet Company (NASDAQ:CENT) fell 17.5% to close at $25.88 after the company reported worse-than-expected Q4 earnings.
- Safe-T Group Ltd (NASDAQ:SFET) fell 12.7% to close at $5.94 after reporting Q3 results.
- Aravive, Inc. (NASDAQ:ARAV) declined 12.2% to close at $8.25 after the company reported pricing of public offering of common stock at $7.50 per share.
- 89bio, Inc. (NASDAQ:ETNB) shares fell 9.9% to close at $30.12.
- Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) dropped 9.9% to close at $15.71. Verrica Pharmaceuticals announced FDA filing acceptance of New Drug Application for VP-102 for the treatment of molluscum contagiosum.
- Correvio Pharma Corp. (NASDAQ:CORV) fell 9.8% to close at $2.12.
- Enochian Biosciences Inc. (NASDAQ:ENOB) dropped 9.4% to close at $5.96.
- Daktronics, Inc. (NASDAQ:DAKT) dipped 8.7% to close at $6.28 after the company reported downbeat Q2 results.
- Capstone Turbine Corporation (NASDAQ:CPST) fell 8.6% to close at $3.96.
- Marker Therapeutics, Inc. (NASDAQ:MRKR) dropped 8.4% to close at $3.05.
- Seres Therapeutics, Inc. (NASDAQ:MCRB) dipped 8.1% to close at $3.90.
- NetSol Technologies, Inc. (NASDAQ:NTWK) shares declined 8% to close at $3.68.
- TechTarget, Inc. (NASDAQ:TTGT) dropped 7.9% to close at $26.53.
- Deere & Company (NYSE:DE) fell 4.3% to close at $169.06 after the company expected a decline in agricultural and construction sales for FY20.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.